PAR 2.56% 20.0¢ paradigm biopharmaceuticals limited..

Ann: Osteoarthritis pain reduced by Paradigms Zilosul (PPS), page-32

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 54 Posts.
    lightbulb Created with Sketch. 15

    The Peer review report was published on Plos-one on the 26th September. Word would have gotten out about this shortly thereafter.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.